SSII · CIK 0001676163 · operating
A commercial-stage surgical robotics company headquartered in Gurugram, India, SS Innovations International develops and markets robotic surgical systems and associated instrumentation for minimally invasive procedures. The company's core offering is SSi Mantra, a surgical robotic platform, complemented by SSi Mudra, a line of stapling, energy, and core instruments designed for robotic-assisted surgery. The company manufactures instrument tips including forceps, scissors, electrocautery tools, and scalpels, along with accessory products such as sterile drapes, endoscopes, cannulas, and seals.
Beyond hardware, the company develops software and digital health solutions including SSi Maya XR, a preoperative simulator for robotic surgery training; SSi Holographic Anatomy, an augmented reality visualization tool; and SSi Chitrasa, an artificial intelligence-enabled medical imaging viewer. The portfolio also includes SSi Mixed Reality Headset, a medical-grade device for surgical applications, alongside tele proctoring and telesurgery platforms that support remote surgical guidance and training.
The company distributes its products through direct sales organizations and distributor networks across India and international markets. Operating with 378 full-time employees, SS Innovations International generates revenue across multiple streams including product sales, recurring service contracts (installation, maintenance, 24/7 technical support, and system health monitoring), and software licensing. The company is incorporated in Florida and trades on Nasdaq.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.11 | $-0.11 | +31.3% | |
| 2023 | $-0.16 | $-0.16 | -220.0% | |
| 2022 | $-0.05 | $-0.05 | +0.0% | |
| 2021 | $-0.05 | $-0.05 | +0.0% | |
| 2020 | $-0.05 | $-0.05 | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-04-15 | 0001213900-25-031773 | SEC ↗ |
| 2023-12-31 | 2024-03-22 | 0001213900-24-025140 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001213900-23-025143 | SEC ↗ |
| 2021-12-31 | 2022-11-04 | 0001213900-22-069119 | SEC ↗ |
| 2020-12-31 | 2022-09-06 | 0001213900-22-054262 | SEC ↗ |
| 2019-12-31 | 2022-02-22 | 0001213900-22-008544 | SEC ↗ |
| 2018-12-31 | 2019-04-16 | 0001615774-19-005795 | SEC ↗ |
| 2017-12-31 | 2018-03-29 | 0001615774-18-002200 | SEC ↗ |